Lipid-rich Plaques Predict Non-target-lesion Ischemic Events in Patients Undergoing Percutaneous Coronary Intervention
Overview
Authors
Affiliations
Background: Despite growing interest in non-target lesion events in patients undergoing percutaneous coronary intervention (PCI), there has been little discussion of predictors.
Methods And Results: A total of 155 consecutive patients who underwent PCI were enrolled. Conventional and integrated backscatter intravascular ultrasound (IB-IVUS) parameters were measured in non-target lesions utilizing a 40-MHz intravascular catheter. Lipid-rich plaques (LRP) were defined as lesions with an increased lipid volume (> median) and greater lipid content. Non-target ischemic events were defined as death, non-fatal myocardial infarction, any repeat revascularization and rehospitalization for angina involving the non-target vessel or the target vessel outside the index lesion. During the follow-up period (median: 1,265 days), non-target events were observed in 16 patients (11%). Using the Cox proportional hazard model, LRP (odds ratio [OR], 6.06; 95% confidence interval [CI]: 1.81-20.4, P = 0.0035), elevated serum C-reactive protein (CRP) levels (OR, 6.83; 95%CI: 2.19-21.3, P = 0.0009) and acute coronary syndrome present at baseline (OR, 4.08; 95%CI: 1.21-13.8, P = 0.024) were significantly and independently associated with non-target events. Synergistic effects of LRP and elevated serum CRP levels for prediction of non-target events (OR, 14.8; 95%CI: 4.57-48.0, P < 0.0001) were found even after adjusting for confounders.
Conclusions: LRP measured using IB-IVUS proved to be an independent morphologic predictor of non-target ischemic events after PCI, particularly enhancing the risk in patients with elevated serum CRP levels.
Lungu C, Creteanu A, Mehedinti M Life (Basel). 2024; 14(4).
PMID: 38672722 PMC: 11051410. DOI: 10.3390/life14040451.
Zhang W, Gu N, Qiu Z, Pan L, Zhao Y, Shi B J Cardiovasc Pharmacol. 2023; 83(6):646-654.
PMID: 38030142 PMC: 11149940. DOI: 10.1097/FJC.0000000000001520.
Takata K, Imaizumi S, Iwata A, Zhang B, Kawachi E, Miura S Biomolecules. 2023; 13(9).
PMID: 37759677 PMC: 10526738. DOI: 10.3390/biom13091278.
Quan W, Han H, Liu L, Sun Y, Zhu Z, Du R J Clin Med. 2023; 12(3).
PMID: 36769433 PMC: 9917377. DOI: 10.3390/jcm12030785.
Vascular Lesion-Specific Drug Delivery Systems: JACC State-of-the-Art Review.
Marlevi D, Edelman E J Am Coll Cardiol. 2021; 77(19):2413-2431.
PMID: 33985687 PMC: 8238531. DOI: 10.1016/j.jacc.2021.03.307.